1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue 1.4 Covid-19 Implications on Market by Type 1.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Chromosomal Abnormalities 1.4.3 X-linked Diseases 1.4.4 Freeze Embryo Testing 1.4.5 Aneuploidy Screening 1.4.6 HLA 1.4.7 Others 1.5 Covid-19 Implications on Market by Application 1.5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2026 1.5.2 Stem Cell Therapy 1.5.3 IVF Prognosis 1.5.4 Late-Onset Genetic Disorders 1.5.5 Inherited Genetic Disease 1.5.6 Others 1.6 Coronavirus Disease 2019 (Covid-19): Pre-Implantation Genetic Diagnosis (PGD) Industry Impact 1.6.1 How the Covid-19 is Affecting the Pre-Implantation Genetic Diagnosis (PGD) Industry 1.6.1.1 Pre-Implantation Genetic Diagnosis (PGD) Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Pre-Implantation Genetic Diagnosis (PGD) Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Pre-Implantation Genetic Diagnosis (PGD) Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Covid-19 Implications on Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2015-2026) 2.2 Covid-19 Implications on Global Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Regions 2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2015-2020) 2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Pre-Implantation Genetic Diagnosis (PGD) Market Growth Strategy 2.3.6 Primary Interviews with Key Pre-Implantation Genetic Diagnosis (PGD) Players (Opinion Leaders) 3 Covid-19 Implications on Competition Landscape by Key Players 3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Market Size 3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2015-2020) 3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2015-2020) 3.1.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio 3.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2019 3.3 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served 3.4 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service 3.5 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Covid-19 Implications on Market Size by Type (2015-2026) 4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2015-2020) 4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2021-2026) 5 Covid-19 Implications on Market Size by Application (2015-2026) 5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 6.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in North America (2019-2020) 6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 7.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Europe (2019-2020) 7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 8 China 8.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 8.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in China (2019-2020) 8.3 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 8.4 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 9.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Japan (2019-2020) 9.3 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 9.4 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 10.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 10.4 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 11 India 11.1 India Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 11.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in India (2019-2020) 11.3 India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 11.4 India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 12.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Central & South America (2019-2020) 12.3 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 12.4 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Roche 13.1.1 Roche Company Details 13.1.2 Roche Business Overview and Its Total Revenue 13.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)) 13.1.5 Roche Recent Development 13.2 Genea Limited 13.2.1 Genea Limited Company Details 13.2.2 Genea Limited Business Overview and Its Total Revenue 13.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.2.5 Genea Limited Recent Development 13.3 Quest Diagnostics 13.3.1 Quest Diagnostics Company Details 13.3.2 Quest Diagnostics Business Overview and Its Total Revenue 13.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.3.5 Quest Diagnostics Recent Development 13.4 Illumina, Inc. 13.4.1 Illumina, Inc. Company Details 13.4.2 Illumina, Inc. Business Overview and Its Total Revenue 13.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.4.5 Illumina, Inc. Recent Development 13.5 Natera, Inc. 13.5.1 Natera, Inc. Company Details 13.5.2 Natera, Inc. Business Overview and Its Total Revenue 13.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.5.5 Natera, Inc. Recent Development 13.6 Cooper Medical, Inc. 13.6.1 Cooper Medical, Inc. Company Details 13.6.2 Cooper Medical, Inc. Business Overview and Its Total Revenue 13.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.6.5 Cooper Medical, Inc. Recent Development 13.7 LabCorp 13.7.1 LabCorp Company Details 13.7.2 LabCorp Business Overview and Its Total Revenue 13.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.7.5 LabCorp Recent Development 13.8 California Pacific Medical Center (CPMC) 13.8.1 California Pacific Medical Center (CPMC) Company Details 13.8.2 California Pacific Medical Center (CPMC) Business Overview and Its Total Revenue 13.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.8.5 California Pacific Medical Center (CPMC) Recent Development 13.9 Thermo Fisher Scientific Inc. 13.9.1 Thermo Fisher Scientific Inc. Company Details 13.9.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue 13.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.9.5 Thermo Fisher Scientific Inc. Recent Development 13.10 IGENOMIX 13.10.1 IGENOMIX Company Details 13.10.2 IGENOMIX Business Overview and Its Total Revenue 13.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.10.5 IGENOMIX Recent Development 13.11 Reproductive Genetic Innovations 10.11.1 Reproductive Genetic Innovations Company Details 10.11.2 Reproductive Genetic Innovations Business Overview and Its Total Revenue 10.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction 10.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 10.11.5 Reproductive Genetic Innovations Recent Development 13.12 CombiMatrix 10.12.1 CombiMatrix Company Details 10.12.2 CombiMatrix Business Overview and Its Total Revenue 10.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction 10.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 10.12.5 CombiMatrix Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Pre-Implantation Genetic Diagnosis (PGD) Key Market Segments Table 2. Key Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue Table 3. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Chromosomal Abnormalities Table 6. Key Players of X-linked Diseases Table 7. Key Players of Freeze Embryo Testing Table 8. Key Players of Aneuploidy Screening Table 9. Key Players of HLA Table 10. Key Players of Others Table 11. COVID-19 Impact Global Market: (Four Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast Scenarios) Table 12. Opportunities and Trends for Pre-Implantation Genetic Diagnosis (PGD) Players in the COVID-19 Landscape Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 14. Key Regions/Countries Measures against Covid-19 Impact Table 15. Proposal for Pre-Implantation Genetic Diagnosis (PGD) Players to Combat Covid-19 Impact Table 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (US$ Million): 2020 VS 2026 Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (2015-2020) (US$ Million) Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2015-2020) Table 20. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 21. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2021-2026) Table 22. Market Top Trends Table 23. Key Drivers: Impact Analysis Table 24. Key Challenges Table 25. Pre-Implantation Genetic Diagnosis (PGD) Market Growth Strategy Table 26. Main Points Interviewed from Key Pre-Implantation Genetic Diagnosis (PGD) Players Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2015-2020) (Million US$) Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players (2015-2020) Table 29. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2019) Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) by Players Market Concentration Ratio (CR5 and HHI) Table 31. Key Players Headquarters and Area Served Table 32. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service Table 33. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 36. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Type (2015-2020) Table 37. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2021-2026) Table 38. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2015-2020) Table 39. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 40. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2021-2026) Table 41. North America Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 42. North America Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 43. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 44. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 45. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 46. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 47. Europe Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 48. Europe Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 49. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 50. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 51. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 52. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 53. China Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 54. China Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 55. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 56. China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 57. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 58. China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 59. Japan Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 60. Japan Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 61. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 62. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 63. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 64. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 65. Southeast Asia Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 66. Southeast Asia Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 67. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 68. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 69. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 70. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 71. India Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 72. India Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 73. India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 74. India Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 75. India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 76. India Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 77. Central & South America Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$) Table 78. Central & South America Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020) Table 79. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$) Table 80. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020) Table 81. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$) Table 82. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020) Table 83. Roche Company Details Table 84. Roche Business Overview Table 85. Roche Product Table 86. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 87. Roche Recent Development Table 88. Genea Limited Company Details Table 89. Genea Limited Business Overview Table 90. Genea Limited Product Table 91. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 92. Genea Limited Recent Development Table 93. Quest Diagnostics Company Details Table 94. Quest Diagnostics Business Overview Table 95. Quest Diagnostics Product Table 96. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 97. Quest Diagnostics Recent Development Table 98. Illumina, Inc. Company Details Table 99. Illumina, Inc. Business Overview Table 100. Illumina, Inc. Product Table 101. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 102. Illumina, Inc. Recent Development Table 103. Natera, Inc. Company Details Table 104. Natera, Inc. Business Overview Table 105. Natera, Inc. Product Table 106. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 107. Natera, Inc. Recent Development Table 108. Cooper Medical, Inc. Company Details Table 109. Cooper Medical, Inc. Business Overview Table 110. Cooper Medical, Inc. Product Table 111. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 112. Cooper Medical, Inc. Recent Development Table 113. LabCorp Company Details Table 114. LabCorp Business Overview Table 115. LabCorp Product Table 116. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 117. LabCorp Recent Development Table 118. California Pacific Medical Center (CPMC) Business Overview Table 119. California Pacific Medical Center (CPMC) Product Table 120. California Pacific Medical Center (CPMC) Company Details Table 121. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 122. California Pacific Medical Center (CPMC) Recent Development Table 123. Thermo Fisher Scientific Inc. Company Details Table 124. Thermo Fisher Scientific Inc. Business Overview Table 125. Thermo Fisher Scientific Inc. Product Table 126. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 127. Thermo Fisher Scientific Inc. Recent Development Table 128. IGENOMIX Company Details Table 129. IGENOMIX Business Overview Table 130. IGENOMIX Product Table 131. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 132. IGENOMIX Recent Development Table 133. Reproductive Genetic Innovations Company Details Table 134. Reproductive Genetic Innovations Business Overview Table 135. Reproductive Genetic Innovations Product Table 136. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 137. Reproductive Genetic Innovations Recent Development Table 138. CombiMatrix Company Details Table 139. CombiMatrix Business Overview Table 140. CombiMatrix Product Table 141. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$) Table 142. CombiMatrix Recent Development Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2020 VS 2026 Figure 2. Chromosomal Abnormalities Features Figure 3. X-linked Diseases Features Figure 4. Freeze Embryo Testing Features Figure 5. Aneuploidy Screening Features Figure 6. HLA Features Figure 7. Others Features Figure 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2026 Figure 9. Stem Cell Therapy Case Studies Figure 10. IVF Prognosis Case Studies Figure 11. Late-Onset Genetic Disorders Case Studies Figure 12. Inherited Genetic Disease Case Studies Figure 13. Others Case Studies Figure 14. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth 2015-2026 (US$ Million) Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions: 2020 VS 2026 Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2021-2026) Figure 18. Porter's Five Forces Analysis Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2019 Figure 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2019 Figure 21. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2019 Figure 22. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 24. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 27. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 31. Genea Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 33. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 35. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 37. Natera, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 39. Cooper Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 41. LabCorp Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 43. California Pacific Medical Center (CPMC) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 45. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 47. IGENOMIX Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 49. Reproductive Genetic Innovations Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 51. CombiMatrix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Roche Genea Limited Quest Diagnostics Illumina, Inc. Natera, Inc. Cooper Medical, Inc. LabCorp California Pacific Medical Center (CPMC) Thermo Fisher Scientific Inc. IGENOMIX Reproductive Genetic Innovations CombiMatrix